|
Volumn 46, Issue 4, 2005, Pages 787-
|
Si tacuisses...[1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETIC ACID;
BETA 2 MICROGLOBULIN;
BIOFILTRATION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
FLUID THERAPY;
HEMODIALYSIS;
HEMOFILTRATION;
HUMAN;
LETTER;
MORTALITY;
RISK ASSESSMENT;
CHRONIC KIDNEY FAILURE;
CONTROLLED CLINICAL TRIAL;
HEMODIAFILTRATION;
METHODOLOGY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RENAL REPLACEMENT THERAPY;
RISK;
SAMPLE SIZE;
STATISTICS;
HEMODIAFILTRATION;
HUMANS;
KIDNEY FAILURE, CHRONIC;
RANDOMIZED CONTROLLED TRIALS;
RENAL DIALYSIS;
RISK;
SAMPLE SIZE;
|
EID: 25644450441
PISSN: 02726386
EISSN: None
Source Type: Journal
DOI: 10.1053/j.ajkd.2005.06.025 Document Type: Letter |
Times cited : (2)
|
References (3)
|